Send a textWe explore a different aspect of the COVID response, speaking with Stephen Bourke (Co-Founder of Echo), to learn how Echo and other tech companies have been supporting patients with new ways of accessing healthcare, throughout lockdown.In this COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) is joined by NHS and other UK healthcare experts who offer real-world, first-hand insight into the challenges facing the NHS and explore the implications for market access, brand and HCP-facing teams, in pharmaceutical and medical device companies. In this episode, Tom asked Stephen: - Can you briefly outline Echo’s origins and purpose?- How soon did you sense that Echo would have a key role to play in the national COVID response?- Can you talk us through the impact the pandemic has had on Echo, in terms of your need to upscale and respond?- What have you noticed about the Echo patients population? – numbers, demographics, behaviours, etc?- What have you noticed in other areas of health tech through this period?- We have heard from many NHS colleagues that this is a ‘tipping point’ in care delivery, do you sense that for Echo and digital healthcare?- What needs to happen to embed the positive behaviours and technologies in ‘the new normal’?- What are the risks to digital healthcare in a post-Covid world?- What advice would you give to anyone looking to design or implement digital health innovation?This episode was originally broadcast on 12th June 2020 as a webinar. This podcast series has been converted from our webinar series 'How is COVID-19 impacting the NHS?'. Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/ Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related